How long can an intragastric balloon remain in the stomach safely? a rare case report on 5.5 years of asymptomatic retention

dc.contributor.authorGençtürk, Mehmet
dc.contributor.authorDalkılıç, Muhammed Said
dc.contributor.authorErdem, Hasan
dc.contributor.authorŞişik, Abdullah
dc.date.accessioned2025-08-28T11:08:28Z
dc.date.available2025-08-28T11:08:28Z
dc.date.issued2025
dc.departmentFakülteler, Sağlık Bilimleri Fakültesi, Hemşirelik Bölümü
dc.description.abstractIntragastric balloons (IGBs) are widely used as a minimally invasive weight loss intervention for patients with obesity. While the recommended implantation period for most IGBs is 6 to 12 months, exceeding this duration is associated with an increased risk of complications such as deflation, migration, obstruction, and gastric perforation. However, the long-term safety of retained IGBs remains inadequately studied. We report a rare case of an asymptomatic 5.5-year retention of a Spatz3 IGB in a 29-year-old male patient. Initially implanted for obesity management with a body mass index (BMI) of 38 kg/m2, the patient experienced an initial 15 kg weight loss, followed by partial weight regain. Despite multiple attempts to schedule removal, the patient postponed the procedure due to personal reasons and was lost to follow-up. Upon returning 5.5 years later, he remained asymptomatic with a BMI of 37.3 kg/m2. Endoscopic examination revealed an intact gastric mucosa and a fully inflated balloon without evidence of degradation or leakage. The balloon was successfully removed endoscopically under sedation, and the postoperative course was uneventful. This case highlights that, under certain conditions, IGBs may remain intact beyond their recommended duration without causing immediate complications. However, this should not be interpreted as evidence of safety, as prolonged retention poses significant risks. Regular patient education, adherence to follow-up schedules, and improved tracking systems are crucial to prevent unintended long-term IGB retention and its associated complications.
dc.identifier.doi10.1007/s11695-025-07744-5
dc.identifier.endpage1192
dc.identifier.issn0960-8923
dc.identifier.issn1708-0428
dc.identifier.issue3
dc.identifier.pmid39932526
dc.identifier.scopus2-s2.0-85217755064
dc.identifier.scopusqualityN/A
dc.identifier.startpage1190
dc.identifier.urihttps://doi.org/10.1007/s11695-025-07744-5
dc.identifier.urihttps://hdl.handle.net/11501/2327
dc.identifier.volume35
dc.identifier.wosWOS:001419015700001
dc.identifier.wosqualityQ1
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.institutionauthorErdem, Hasan
dc.institutionauthorŞişik, Abdullah
dc.institutionauthorid0000-0002-2178-7362
dc.institutionauthorid0000-0002-7500-8651
dc.language.isoen
dc.publisherSpringer
dc.relation.ispartofObesity Surgery
dc.relation.publicationcategoryDiğer
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.subjectBariatric Endoscopy
dc.subjectEndoscopic Removal
dc.subjectIntragastric Balloon
dc.subjectObesity Management
dc.subjectProlonged Retention
dc.titleHow long can an intragastric balloon remain in the stomach safely? a rare case report on 5.5 years of asymptomatic retention
dc.typeLetter

Dosyalar

Orijinal paket
Listeleniyor 1 - 1 / 1
Kapalı Erişim
İsim:
Tam Metin / Full Text
Boyut:
592.81 KB
Biçim:
Adobe Portable Document Format
Lisans paketi
Listeleniyor 1 - 1 / 1
Kapalı Erişim
İsim:
license.txt
Boyut:
1.17 KB
Biçim:
Item-specific license agreed to upon submission
Açıklama: